Literature DB >> 18763422

The quest for stability in an unstable world: adaptive servoventilation in opioid induced complex sleep apnea syndrome.

Timothy I Morgenthaler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763422      PMCID: PMC2542502     

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  13 in total

1.  Complex sleep apnea syndrome: is it a unique clinical syndrome?

Authors:  Timothy I Morgenthaler; Vadim Kagramanov; Viktor Hanak; Paul A Decker
Journal:  Sleep       Date:  2006-09       Impact factor: 5.849

2.  Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section.

Authors: 
Journal:  Anesthesiology       Date:  1997-04       Impact factor: 7.892

Review 3.  Recognition and management of complex sleep-disordered breathing.

Authors:  Geoffrey S Gilmartin; Robert W Daly; Robert J Thomas
Journal:  Curr Opin Pulm Med       Date:  2005-11       Impact factor: 3.155

4.  Increase in poisoning deaths caused by non-illicit drugs--Utah, 1991-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-01-21       Impact factor: 17.586

5.  Sleep-disordered breathing in stable methadone programme patients: a pilot study.

Authors:  H Teichtahl; A Prodromidis; B Miller; G Cherry; I Kronborg
Journal:  Addiction       Date:  2001-03       Impact factor: 6.526

6.  Central sleep apnea in stable methadone maintenance treatment patients.

Authors:  David Wang; Harry Teichtahl; Olaf Drummer; Cathy Goodman; Gaye Cherry; David Cunnington; Ian Kronborg
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

7.  Trends in medical use and abuse of opioid analgesics.

Authors:  D E Joranson; K M Ryan; A M Gilson; J L Dahl
Journal:  JAMA       Date:  2000-04-05       Impact factor: 56.272

8.  Sleep-disordered breathing associated with long-term opioid therapy.

Authors:  Robert J Farney; James M Walker; Tom V Cloward; Steven Rhondeau
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

9.  Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids.

Authors:  Shahrokh Javaheri; Athar Malik; Jason Smith; Eugene Chung
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

10.  Adaptive servoventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medications for non-malignant pain.

Authors:  Robert J Farney; James M Walker; Kathleen M Boyle; Tom V Cloward; Kevin C Shilling
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

View more
  6 in total

1.  Obstructive sleep apnea and chronic opioid use.

Authors:  Christian Guilleminault; Michelle Cao; Herbert J Yue; Pawan Chawla
Journal:  Lung       Date:  2010-07-24       Impact factor: 2.584

2.  Quality measures for the care of patients with insomnia.

Authors:  Jack D Edinger; Daniel J Buysse; Ludmila Deriy; Anne Germain; Daniel S Lewin; Jason C Ong; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

3.  A retrospective case series of adaptive servoventilation for complex sleep apnea.

Authors:  Stephen E Brown; Sarah S Mosko; James A Davis; R Ander Pierce; Tamera V Godfrey-Pixton
Journal:  J Clin Sleep Med       Date:  2011-04-15       Impact factor: 4.062

4.  Adaptive servoventilation for treatment of opioid-associated central sleep apnea.

Authors:  Shahrokh Javaheri; Nicholas Harris; Joseph Howard; Eugene Chung
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

5.  Clinical heterogeneity of patients with complex sleep apnea syndrome.

Authors:  Tomasz J Kuźniar; Kamilla Kasibowska-Kuźniar; Daniel W Ray; Thomas Freedom
Journal:  Sleep Breath       Date:  2013-02-23       Impact factor: 2.816

6.  Complex sleep apnea syndrome.

Authors:  Juan Wang; Yan Wang; Jing Feng; Bao-Yuan Chen; Jie Cao
Journal:  Patient Prefer Adherence       Date:  2013-07-03       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.